The landscape of health policy, technology, and operations demands that professionals stay on top of key trends in the healthcare payer and provider, life sciences and pharmaceutical industries. PricewaterhouseCoopers' health industry publications focus on trends as well as key insights and best practices.
Strong medicine required
The 2009 Winter Issue of View, a PwC business magazine, includes a new piece of thought leadership entitled, Strong medicine required. The report explores how the combined impact of a slowing economy, increasing healthcare costs and a new administration in Washington D.C. will impact a business’s bottom line in the coming year and beyond. The report also looks at how businesses can effectively balance these costs with the need to attract and retain a productive workforce.
Top nine health industry issues in 2009
In 2009, external forces will compel health industry organizations to react to new financial realities, regulations, and technology. Chief among those forces will be the effects of the economic crisis, a new president and Congress, and financial and technology companies looking to extend their reach into the health industry. PricewaterhouseCoopers' report from the Health Research Institute (HRI) identifies nine significant issues that will shape the health industry in 2009. To find out more about these nine issues and their implications read,
Top nine health industry issues in 2009.
Proposals to policy: A national conversation on healthcare reform
Susan Dentzer, editor-in-chief of Health Affairs and health correspondent of The NewsHour with Jim Lehrer, moderated a panel of healthcare experts, economists and lawmakers as they discussed President-elect Obama's health care reform proposals. This broadcast was recorded from the National Press Club, Washington, D.C. on November 20, 2008.
Research rewired: Merging care and research information to improve knowledge discovery
Today's ad hoc methods of managing research information are beginning to strain under increasing demands for new drugs, more personalized medicine, better diagnostic tools, and post-market safety monitoring. This report investigates the benefits, barriers, and emerging approaches to creating an integrated information environment that will help to shape scientific diagnostic, drug, and device discovery in the future. See more
Top eight health industry issues in 2008
Health organizations face a pivotal year in 2008 as they anticipate the wildcard outcome of the presidential election. Meanwhile, they must prepare for impending changes — pharmaceutical and life sciences companies are adapting to a new safety agenda from the FDA including the agency’s expanded authority over post-market drug safety. See more
Pharma 2020: The vision: Which path will you take?
The current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.